Search results
Results From The WOW.Com Content Network
On Friday, Nasdaq Inc's (NASDAQ:NDAQ) annual reconstitution of the Nasdaq-100 Index will become effective before the market opens on December 23. As a result, Moderna Inc. (NASDAQ:MRNA) was ...
To find out, let's look at some reasons the stock fell despite the good news. Why Moderna stock fell Moderna's bizarre stock price performance during the week ending May 31 had two main factors.
On Monday, Merck & Co Inc (NYSE:MRK) and Moderna, Inc. (NASDAQ:MRNA) announced the initiation of INTerpath-009, a pivotal Phase 3 trial of V940 (mRNA-4157). V940 is an investigational ...
For premium support please call: 800-290-4726 more ways to reach us
Moderna Inc (NASDAQ: MRNA) is trading lower Monday morning after the U.S. Food and Drug Administration delayed approval of the company's Emergency Use Authorization request for the use of its ...
Monday, Moderna, Inc.’s (NASDAQ:MRNA) manufacturing facility in Laval, Quebec, received a Drug Establishment License (DEL) from Health Canada. This certification affirms the facility’s ...
The stock made an attempt to settle below the $140 level.
The company's stock was trading slightly up on the news early Monday before falling after market open. Moderna is up almost 20% in the last month after the company received approval from the FDA ...